The Center for Drug Evaluation & Research’s ability to recruit and retain talent has improved during the COVID-19 pandemic as the US FDA’s drug center is able to offer staff the flexibility to work remotely and has “pivoted” to take full advantage of the salary and hiring authorities under the 21st Century Cures Act.
Speaking at an Alliance for a Stronger FDA webinar on 25 May, CDER Director Patrizia Cavazzoni recalled the first time...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?